No Data
Arcus Biosciences, Inc. (RCUS) Q1 2024 Earnings Call Transcript
Arcus Biosciences, Inc. (RCUS) Q1 2024 Earnings Call Transcript
Arcus Biosciences Q1 2024 GAAP EPS $(0.05) Beats $(0.98) Estimate, Sales $145.000M Beat $33.862M Estimate
Arcus Biosciences (NYSE:RCUS) reported quarterly losses of $(0.05) per share which beat the analyst consensus estimate of $(0.98) by 94.9 percent. This is a 95.41 percent increase over losses of $(1.0
Express News | Arcus Biosciences Inc -Well-Positioned to Advance Full Pipeline With $1.1 Bln in Cash, Cash Equivalents and Marketable Securities and Runway Into 2027
Arcus Biosciences | 10-Q: Quarterly report
Arcus Biosciences 1Q Rev $145M >RCUS
Arcus Biosciences 1Q Rev $145M >RCUS
Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M
04:03 PM EDT, 05/08/2024 (MT Newswires) -- Earnings Flash (RCUS) ARCUS BIOSCIENCES Posts Q1 Revenue $145M